Because in gene expression profiling studies, LMO2 downregulation is observed in BL and DLBCL with MYC translocations, they analyzed LMO2 protein expression in 46 BLs and 284 BLBCL. The gene discussed is LMO2; the disease is diffuse large B-cell lymphoma.